pamidronate has been researched along with Glomerulosclerosis, Focal Segmental in 10 studies
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction." | 8.85 | Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009) |
| "Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells." | 5.33 | Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006) |
| "Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases." | 5.31 | Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001) |
| "The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction." | 4.85 | Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009) |
| "Pamidronate has been mainly associated with collapsing focal segmental glomerulosclerosis." | 3.72 | Podocyte injury associated glomerulopathies induced by pamidronate. ( Abulezz, SR; Barri, YM; Bonsib, SM; Munshi, NC; Sukumalchantra, S; Walker, PD; Wallach, J, 2004) |
| "Collapsing focal segmental glomerulosclerosis is well described in its idiopathic form, mostly seen in young African American patients, and in association with HIV virus." | 2.45 | [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review]. ( Jotterand, V; Martin, PY; Moll, S; Saudan, P, 2009) |
| " Patterns of nephrotoxicity described with these agents include toxic acute tubular necrosis and collapsing focal segmental glomerulosclerosis, respectively." | 2.44 | Bisphosphonate nephrotoxicity. ( Markowitz, GS; Perazella, MA, 2008) |
| "Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells." | 1.33 | Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006) |
| "Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases." | 1.31 | Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perazella, MA | 1 |
| Markowitz, GS | 3 |
| Jotterand, V | 1 |
| Moll, S | 1 |
| Martin, PY | 1 |
| Saudan, P | 1 |
| Nagahama, M | 1 |
| Sica, DA | 1 |
| Yoshizawa, H | 1 |
| Akimoto, T | 1 |
| Nishino, K | 1 |
| Inoue, M | 1 |
| Ito, C | 1 |
| Takeda, S | 1 |
| Kotoda, A | 1 |
| Tamba, K | 1 |
| Yumura, W | 1 |
| Muto, S | 1 |
| Ueda, Y | 1 |
| Kusano, E | 1 |
| Barri, YM | 1 |
| Munshi, NC | 1 |
| Sukumalchantra, S | 1 |
| Abulezz, SR | 1 |
| Bonsib, SM | 1 |
| Wallach, J | 1 |
| Walker, PD | 1 |
| Kunin, M | 1 |
| Kopolovic, J | 1 |
| Avigdor, A | 1 |
| Holtzman, EJ | 1 |
| Nasr, SH | 1 |
| Preddie, DC | 1 |
| Appel, GB | 2 |
| D'Agati, VD | 2 |
| Sauter, M | 1 |
| Jülg, B | 1 |
| Porubsky, S | 1 |
| Cohen, C | 1 |
| Fischereder, M | 1 |
| Sitter, T | 1 |
| Schlondorff, D | 1 |
| Gröne, HJ | 1 |
| Dijkman, HB | 1 |
| Weening, JJ | 1 |
| Smeets, B | 1 |
| Verrijp, KC | 1 |
| van Kuppevelt, TH | 1 |
| Assmann, KK | 1 |
| Steenbergen, EJ | 1 |
| Wetzels, JF | 1 |
| Fine, PL | 1 |
| Fenves, AZ | 1 |
| Loon, NR | 1 |
| Jagannath, S | 1 |
| Kuhn, JA | 1 |
| Dratch, AD | 1 |
3 reviews available for pamidronate and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Bisphosphonate nephrotoxicity.
Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kid | 2008 |
[Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Female; Fractures, Spontaneous | 2009 |
Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
Topics: Aged; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Gl | 2009 |
7 other studies available for pamidronate and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Glomerulosclerosis, Focal S | 2011 |
Podocyte injury associated glomerulopathies induced by pamidronate.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis | 2004 |
Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
Topics: Antineoplastic Agents; Basement Membrane; Diphosphonates; Female; Glomerulosclerosis, Focal Segmenta | 2004 |
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin | 2006 |
Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
Topics: Antineoplastic Agents; Biopsy; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosph | 2006 |
Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.
Topics: AIDS-Associated Nephropathy; Antineoplastic Agents; Biomarkers; Biopsy; Cell Division; Diphosphonate | 2006 |
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis, Focal Seg | 2001 |